Transdermal Nicotine Replacement Therapy's metabolic induction evaluated as nAChR upregulation surrogate

Tobacco consumption remains a significant global health burden, contributing to a wide array of degenerative diseases, including lung cancer and various cardiovascular disorders. Nicotine, the primary addictive component in tobacco, exerts its profound effects primarily by stimulating nicotinic acetylcholine receptors (nAChRs) in the brain and periphery. Chronic nicotine exposure leads to complex adaptations, including the upregulation of these nAChRs, which is a key neurobiological factor in nicotine dependence and withdrawal. Understanding and accurately measuring nAChR upregulation is critical for optimizing nicotine replacement therapy (NRT) strategies, which aim to mitigate withdrawal symptoms and support smoking cessation. Current methods to assess nAChR changes are often invasive, costly, or technically demanding, presenting a significant barrier to routine clinical application and research. There is a clear need for simpler, non-invasive biomarkers that can reliably reflect nAChR activity and modulation, potentially improving the personalization and efficacy of NRT interventions.

This observational study was designed to evaluate whether the phenomenon of auto-induction, a metabolic process, could be utilized as a reliable surrogate measure for nicotinic acetylcholine receptor (nAChR) upregulation. The study protocol involved participants receiving transdermal nicotine replacement therapy (NRT) for a duration of two weeks. Following this active intervention period, participants underwent a subsequent phase of two weeks with no intervention. The primary aim was to assess the metabolic induction occurring during the NRT phase and to determine its potential correlation with changes in nAChR expression or function. The abstract does not specify the exact number of participants (n), the precise dose of nicotine administered, or the specific assays (ELISA, qPCR, PET imaging) used to measure metabolic induction or nAChR status.